Peptides surge in popularity for anti-aging, but a dark gray market poses serious risks. Experts call for oversight. GLP-1 agonists like semaglutide spark a peptide revolution, but unapproved compound...
your path to beautiful life
Peptides surge in popularity for anti-aging, but a dark gray market poses serious risks. Experts call for oversight. GLP-1 agonists like semaglutide spark a peptide revolution, but unapproved compound...